New Benchmark Trend Data Identifies Potential Areas of Risk and Provides Recommended Actions to Protect and Create Portfolio Value NASHVILLE, TN (March 12, 2025) – Clearwater, the largest pure-play provider of cybersecurity and compliance solutions for the...
HIPAA Security Rule Proposed Updates: Addressing Increasing Cyberthreats in Health Care
On January 6, HHS’ Office for Civil Rights published a Notice of Proposed Rulemaking titled “HIPAA Security Rule to Strengthen the Cybersecurity of Electronic Protected Health Information.” Wes Morris, Senior Director of Consulting Services, Clearwater, speaks with...
One year later: Lessons learned from the Change Healthcare cyberattack
David Bailey, vice president of consulting services at Clearwater, a firm focused on cybersecurity in healthcare, told Fierce in an interview that the incident highlighted challenges in healthcare beyond fending off digital threats, as organizations grappled with a key service taken offline.
Key Insights & Top Takeaways from HIMSS25 Day 2
Clearwater CEO Steve Cagle, MBA, HCISPP, CHISL, CDH-E shares 3 key steps to strengthen cybersecurity.
HIMSS25 panel provides tips on combating cybersecurity threats
At HIMSS25, Jon Moore of Clearwater Security and Compliance and Michael Gross at the Cleveland Clinic discussed how to stay ahead of emerging cybersecurity threats.
Press: Clearwater Further Accelerates and Measures Risk Reduction Through New Innovations in its Security Operations Center Portal and IRM|Analysis® Software
Enhanced Intelligence Flowing Through Clearwater’s SOC and Proprietary Software Helps Clients Identify Critical Vulnerabilities, Visualize Trends, and Show Risk Management Progress LAS VEGAS, NV (March 4, 2025) – Clearwater, the largest pure-play provider of...
2024 HIMSS Healthcare Cybersecurity Survey
Key topics include ransomware, security incidents, budgets, and the role and governance of artificial intelligence.
Leverage cyber threat intelligence to stay ahead of cyberattacks
HIMSS25 session on a cybersecurity strategy features experts from the Cleveland Clinic and Clearwater.
Clinical Research Organizations: M&A Goldmine or Cyber Risk Liability?
The market for clinical trials is experiencing significant momentum in mergers and acquisitions (M&A). Private equity (PE) investment in Clinical Research Organizations (CROs) and Site Management Organizations (SMOs) is being spurred by site consolidation, expansion of specialized services, and technology innovation. These firms are important players in the pipeline of drug development and the best targets for investors who wish to capitalize on healthcare innovation.
Background Check, Drug Testing Firm Hack Affects 3.3 Million
Vendor Providing Employee Screenings Across Multiple Sectors Reports Cyber Incident